Assort Health Secures $102M in Funding to Revolutionize Healthcare Call Centers with Voice AI

Assort Health, a pioneering voice AI startup, has successfully raised $76 million in a Series B funding round, bringing its total funding to an impressive $102 million in just four months. The company's innovative platform aims to transform healthcare call centers by deploying specialty-specific voice AI agents across various medical fields.

Substantial Funding Fuels Rapid Expansion

The Series B round, led by Lightspeed Venture Partners, saw participation from notable investors including Felicis, First Round Capital, Chemistry, A*, Liquid2, and Quiet Capital. This latest injection of capital follows closely on the heels of Assort Health's Series A round in April, which was co-led by First Round Capital and Chemistry.

Jon Wang, co-CEO and co-founder of Assort Health, emphasized the company's strong market position, stating, "We didn't raise to cover burn; we raised to scale a platform solving an important patient access problem others haven't been able to solve." The rapid succession of funding rounds underscores the high demand for Assort Health's solution in the healthcare industry.

Advanced AI Technology Streamlines Patient Communication

Assort Health's flagship product, AssortOS, is designed to seamlessly integrate with providers' electronic health records and practice management software. The platform's AI-powered voice agents can handle a wide range of tasks, including:

• Triaging incoming patient calls
• Answering frequently asked questions
• Routing patients to appropriate clinic staff
• Scheduling appointments
• Resolving patient issues efficiently

Jeffery Liu, founder and co-CEO, highlighted the superiority of Assort Health's technology, stating, "Most 'voice AI' is a prompt thrown into a voice pipeline. It's slow to implement, shallow in coverage and prone to unsafe hallucinations. Assort Intelligence delivers end-to-end automation across scheduling, triage and patient comms with industry leading workflow coverage, patient safety and performance guardrails."

Expanding Capabilities and Industry Impact

With the new funding, Assort Health plans to grow its team and further develop the AssortOS platform. The company's voice AI technology has applications beyond basic call center operations, extending to:

• Care navigation
• Lab test coordination
• Prescription renewals
• Physician referrals

The potential for significant industry impact has attracted attention from healthcare leaders. As part of the funding agreement, Dr. Galym Imanbayev, partner at Lightspeed Venture Partners, will join Assort Health's board. Additionally, Paul Ricci, founding CEO of Nuance, will serve as a board advisor, bringing valuable expertise to the company's strategic direction.

Dr. Imanbayev emphasized the importance of Assort Health's mission, stating, "Patient engagement is the vital heartbeat of healthcare organizations both clinically and administratively. We are thrilled to back Assort Health as it leads the re-platforming of patient engagement into the AI-native era with superior experience for patients and unprecedented outcomes for the organizations that care for them."